Join
Live feed
·
PRReleasevia Quantisnow
Global Blood Therapeutics Inc. logo
Pfizer Inc. logo

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GBT (Global Blood Therapeutics Inc.), PFE (Pfizer Inc.) and more on Quantisnow.